Results 91 to 100 of about 2,075 (191)

A review of prevention and management of castration complications

open access: yesEquine Veterinary Education, Volume 36, Issue 2, Page 97-106, February 2024.
Summary Despite castration being one of the most frequently performed elective equine surgical procedures, complication rates are high and range from severe life‐threatening conditions to mild complications that are of no consequence to the horse. This article will briefly review strategies to prevent complications and surgical castration techniques ...
Christopher M. Baldwin
wiley   +1 more source

Rapid response to botulinum antitoxin in hyperhidrosis patient

open access: yesActa Medica
Botox injections are shots that use a toxin to prevent a muscle from moving for a limited time. These shots are often used to smooth wrinkles on the face. They’re also used to treat neck spasms, sweating, overactive bladder, lazy eye and other conditions.
Ferhat Kılıçaslan   +2 more
openaire   +1 more source

Complete paralytic botulism mimicking a deep coma in a child

open access: yesThe Turkish Journal of Pediatrics, 2017
Botulism is a rare cause of neuroparalysis. Delay in diagnosis and treatment exerts adverse impact on mortality and morbidity. We report a child with complete flaccid paralysis followed by progression to coma-like consciousness.
Ebru Azapağası   +5 more
doaj   +1 more source

Whole-genome sequencing completes the traceability of a type B1 botulinum toxin poisoning incident

open access: yesInternational Journal of Infectious Diseases
Objectives: To complete the traceability from patient to food using single nucleotide polymorphism (SNP)–based clustering analysis technology after whole-genome sequencing in botulinum toxin poisoning incidents.
Meng Zhang   +6 more
doaj   +1 more source

An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E. [PDF]

open access: yes, 2018
Safe and effective antitoxins to treat and prevent botulism are needed for biodefense. We have developed recombinant antibody-based therapeutics for botulinum neurotoxin (BoNT) serotypes A, B, and E.
Chidi R. Obi   +14 more
core   +2 more sources

ePoster

open access: yes
European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Hospital-acquired intestinal toxemia botulism in a newly diagnosed adult colon cancer patient

open access: yesRevista do Instituto de Medicina Tropical de São Paulo
This manuscript reports a case of intestinal toxemia botulism in an adult with recently diagnosed metastatic colon cancer in whom botulism symptoms began 23 days after hospital admission.
Lucas José Sá da Fonseca   +8 more
doaj   +1 more source

Toxigenic and non-toxigenic strains of Clostridium botulinum type E : A. Differentiation by immunodiffusion : B. Attempts to induce toxigenicity by mutagenic agents [PDF]

open access: yes
In this study of toxigenic and non-toxigenic strains of Clostridium botulinum type E, attempts were made to induce toxin production in non-toxigenic cultures by exposure to mutagenic agents and to differentiate the organisms by immunodiffusion.
Balstraz, Edwina Gene
core   +1 more source

Algal chloroplast produced camelid VHH antitoxins are capable of neutralizing botulinum neurotoxin [PDF]

open access: yes, 2015
We have produced three antitoxins consisting of the variable domains of camelid heavy chain-only antibodies (VH H) by expressing the genes in the chloroplast of green algae.
Shoemaker, Charles B   +9 more
core   +2 more sources

Investigational heptavalent botulinum antitoxin (HBAT) to replace licensed botulinum antitoxin AB and investigational botulinum antitoxin E.

open access: yesMMWR. Morbidity and mortality weekly report, 2010
CDC announces the availability of a new heptavalent botulinum antitoxin (HBAT, Cangene Corporation) through a CDC-sponsored Food and Drug Administration (FDA) Investigational New Drug (IND) protocol. HBAT replaces a licensed bivalent botulinum antitoxin AB and an investigational monovalent botulinum antitoxin E (BAT-AB and BAT-E, Sanofi Pasteur) with ...
openaire   +1 more source

Home - About - Disclaimer - Privacy